Home Current Issue Previous Issues Published Ahead-of-Print Collections For Authors Journal Info
Skip Navigation LinksHome > July 2010 - Volume 24 - Issue > HIV/AIDS in the Middle East and North Africa: new study meth...
Text sizing:
doi: 10.1097/01.aids.0000386728.49059.92

HIV/AIDS in the Middle East and North Africa: new study methods, results, and implications for prevention and care

McFarland, Willia,b; Abu-Raddad, Laith Jc,d; Mahfoud, Ziyade; DeJong, Jocelyne; Riedner, Gabrielef; Forsyth, Andrewg; Khoshnood, Kavehh

Free Access
Article Outline
Collapse Box

Author Information

aDepartment of Epidemiology and Biostatistics, University of California, USA

bSan Francisco Department of Public Health, San Francisco, California, USA

cWeill Cornell Medical College, Qatar, Cornell University, Qatar Foundation, Education City, Doha, Qatar

dDepartment of Public Health, Weill Cornell Medical College, Cornell University, Ithaca, New York, USA

eFaculty of Health Sciences, American University of Beirut, Beirut, Lebanon

fWorld Health Organization, Regional Office of the Eastern Mediterranean, Cairo, Egypt

gNational Institute of Mental Health, National Institutes of Health, Bethesda, Maryland, USA

hYale School of Public Health, Center for Interdisciplinary Research on AIDS, New Haven, Connecticut, USA.

Correspondence to Willi McFarland, MD, PhD, Director of HIV Epidemiology, San Francisco Department of Public Health, 25 Van Ness Avenue, San Francisco, CA 94102-6033, USA. Tel: +1 415 554 9016; fax: +1 415 533 9882; e-mail: Willi_McFarland@hotmail.com

Of all areas of the world, the Middle East and North Africa (MENA, see Fig. 1 for countries included in this supplement's classification) may engender the most perceptions and misperceptions about the HIV/AIDS epidemic in the face of a paucity of accessible data.

Fig. 1
Fig. 1
Image Tools

The MENA region, for example, is perceived as the area of the world least affected by HIV/AIDS. According to most estimates, the overall prevalence of persons living with HIV/AIDS in the region is well below the world average [1]. On the contrary, there is also the perception that the infection rate is severely underestimated among the marginalized populations most affected by HIV/AIDS, namely injection drug users (IDUs), men who have sex with men (MSM), and female sex workers (FSWs). The seldom-estimated size of these populations [2] and paucity of HIV prevalence and behavioral data from these groups may belie a greater existing burden of disease and the potential for rapidly evolving epidemics in some areas of the MENA.

Another perception is that the threat of HIV to the region comes primarily from outside. Indeed, case reporting, patterns of migration, and molecular epidemiology [3–5] corroborate multiple, diverse origins of HIV from exogenous sources throughout three decades of the epidemic. A self-fulfilling result is that HIV testing is often targeted disproportionately to immigrant populations in many countries of the region [6]. Yet, there is also emerging evidence of sustained endogenous HIV transmission among most-at-risk populations including IDUs, MSM, and FSWs [4]. An effective response for the MENA must, therefore, also be home grown and based on locally appropriate research among these populations [7–12].

It is also widely perceived that political and sociocultural sensitivities restrict access to HIV-related data and stifle relevant research in the MENA. Although these factors may contribute to the apparent lack of data, limited experience and capacity in designing, conducting, and disseminating the findings of local HIV research are also severe barriers.

Fortunately, concerted efforts to address these barriers and move the field of HIV/AIDS research in the MENA from perception and misperception to a sound evidence base are being scaled up. For example, the US National Institutes of Health (NIH) has recognized the need for new HIV/AIDS research in the region and, since 2006, has supported meetings in Cairo, Tunis, Beirut, Rabat, and elsewhere in order to improve understanding of the epidemiology of HIV/AIDS in the region; to stimulate productive research collaborations between United States and MENA-based investigators; and generate innovative research grant submissions. One conclusion from these meetings was the need to increase the visibility of recent research from the MENA through publications in high impact, peer-reviewed scientific journals. Also, the World Health Organization (WHO) and the United Nations Joint Programme on HIV/AIDS have focused their investment in recent years on training of national experts on state-of-the art methodologies for community-based surveys among IDUs, MSM, male sex workers, and FSWs, in addition to providing technical and financial support to such epidemiological studies.

This supplement to AIDS is an output of these concerted efforts to build research and scientific writing capacity and promote timely dissemination of recent HIV/AIDS research findings from the MENA. Several of the guest editors of this supplement first met at the Tunis conference and the American University of Beirut (AUB) subsequently organized a workshop in Beirut with funding from the Ford Foundation. At that meeting, researchers shared epidemiological and behavioral research findings, discussed common methodological and ethical challenges, and concurred on a complementary set of articles to prioritize for publication. A second workshop in Beirut, funded by the WHO Eastern Mediterranean Regional Office (EMRO) and the Ford Foundation (Regional Office for the MENA), included an intensive 10-day didactic and mentored retreat to generate 10 manuscripts for simultaneous publication in this supplement funded by the National Institute of Mental Health (NIMH). The articles herein testify to the success of these workshops, the dedication of the authors, and the political support of their respective countries to make their data publicly available.

The first article [4] is based on the MENA HIV/AIDS Synthesis Project [13] and is the most comprehensive effort to gather and synthesize all available data on HIV/AIDS in the MENA to date, identifying and interpreting several thousand sources from the published and grey literature. Contrary to perception, there is a considerable quantity of epidemiological data on HIV/AIDS in the MENA, though fragmented across different disciplines, organizations, and geographic levels. A large number of focused assessments, reviews, and studies have never been published; are not easily accessible; and are disseminated only within small circles as confidential or unofficial reports. An encouraging conclusion of the review is that the quality of data from the region has steadily improved in recent years. The second article also synthesizes existing information from across the region, focusing on HIV testing and counseling practices and policies and complemented with original fieldwork in Oman, Egypt, Sudan, and Pakistan [6]. The work describes the predominance of mandatory testing in many countries, particularly targeting migrant and foreign workers, and highlights the need for true voluntary testing with accessibility to the populations most at risk.

The majority of articles in this supplement present the first integrated biological and behavioral surveillance data for several countries, applying state-of-the-art methods, such as respondent-driven sampling (RDS) to survey FSWs, IDUs, and MSM in Lebanon [7]; IDUs in Egypt [8]; FSWs in Sudan [10] and Somalia [11]; and variations of venue-based or time-location sampling (TLS) to survey FSWs in Afghanistan [12] and street children in Egypt [9]. These studies demonstrate the feasibility of reaching hidden populations even under the higher real or perceived stigma affecting MSM, FSWs, and IDUs in the MENA. The studies describe the unique challenges and locally generated methodological solutions in implementing RDS and TLS in the region. One study [2] from Pakistan presents the development and application of a pragmatic yet comprehensive method to estimate the size of hidden populations, an underappreciated first step absolutely necessary in guiding the public health response to the HIV/AIDS epidemic worldwide. The final article includes updated data on antiretroviral drug resistance mutations in Iran, a testament to that country's regional scientific leadership [5].

A final misperception that merits careful consideration is that the MENA is homogeneous in ways protective against HIV. The near universality of Islam with accompanying male circumcision and probably limited connectivity of sexual networks due to conservative cultural norms may slow HIV transmission [4,13]. Indeed, with the possible exception of parts of Sudan, sustainable HIV epidemics in the general population have generally not occurred in the region. However, the MENA is not homogeneous culturally or epidemiologically. A listing of the countries included in our definition of the MENA makes this clear: Afghanistan, Algeria, Bahrain, Djibouti, Egypt, Islamic Republic of Iran, Iraq, Jordan, Kuwait, Lebanon, Libyan Arab Jamahiriya, Morocco, Oman, Pakistan, Qatar, Saudi Arabia, Somalia, Sudan, Syrian Arab Republic, Tunisia, United Arab Emirates, Yemen, and the occupied Palestinian territories (Fig. 1). In the region's southern front (Sudan, Somalia, and Djibouti), generalized epidemics may have occurred in at least parts of one of these countries. The MENA's eastern flank includes the world's number one producer (Afghanistan) and per capita consumer (Iran) of opioids with accompanying serious HIV epidemics among IDUs. Throughout the region, male–male sexual behavior and sex work exist largely under the radar, but in some areas increasingly openly despite strong stigma and severe legal and social proscription.

In conclusion, the diversity of the populations at risk and the contexts in which they find themselves in the MENA require innovative, tailored responses guided by rigorous local research. We also conclude that there is no cause for complacency anywhere in the region. Our hope is that this supplement will give voice to a part of the world that has been relatively underrepresented in the scientific literature in order to accelerate research and advocate for more vigorous and effective prevention and care programs. It is our perception that there is still a window of opportunity to prevent the further spread of HIV in each of the countries of the MENA.

Back to Top | Article Outline


This supplement was made possible by the Faculty of Health Sciences of the AUB through hosting regional workshops to build scientific writing capacity, donating faculty time and mentorship, and providing scientific guidance to bring the articles herein to fruition. The authors are also grateful to the AUB for their gracious hospitality, the serenity afforded by the use of their campus, and their attentive logistical support. Funding for the production of this supplement was provided by the Ford Foundation (Cairo Regional Office), the EMRO of the WHO, and the NIMH of the US NIH. Individual studies presented within this supplement were supported by the institutions and organizations indicated within each article.

This work was written as part of Andrew D. Forsyth's official duties as a Government employee. The views expressed in this article do not necessarily represent the views of the NIMH, NIH, Health and Human Services, or the United States Government.

Back to Top | Article Outline


1. UNAIDS. AIDS epidemic update [UNAIDS/09.36E/JC1700E]; November 2009.

2. Emmanuel F, Blanchard J, Zaheer HA, Reza T, Holt-McKenzie M, The HASP Team. The HIV/AIDS Surveillance Project mapping approach: an innovative approach for mapping and size estimation for groups at higher risk of HIV in Pakistan. AIDS 2010; 24(suppl 2):S77–S84.

3. Mumtaz G, Hilmi N, Akala FA, Semini I, Riedner G, Wilson D, Abu-Raddad LJ. HIV-1 molecular epidemiology evidence and transmission patterns in the Middle East and North Africa. Sexually Transm Infect (in press).

4. Abu-Raddad LJ, Hilma N, Mumtaz G, Benkirane M, Akala FA, Riedner G, et al. Epidemiology of HIV infection in the Middle East and North Africa. AIDS 2010; 24(suppl 2):S5–S23.

5. Hamkar R, Mohraz M, Lorestani S, Aghakahni A, Truong H-HM, McFarland W, et al. Assessing sub-type and drug-resistance associated mutations among antiretroviral-treated HIV-infected patients. AIDS 2010; 24(suppl 2):S85–S91.

6. Hermez J, Petrak J, Karkouri M, Riedner G. A review of HIV testing and counseling policies and practices in the Eastern Mediterranean Region. AIDS 2010; 24(suppl 2):S25–S32.

7. Mahfoud Z, Afifi R, Ramia S, El Khoury D, Kassek K, El Barbir F, et al. HIV/AIDS among female sex workers, injection drug users and men who have sex with men in Lebanon: Results of the first bio-behavioral surveys. AIDS 2010; 24(suppl 2):S45–S54.

8. Soliman C, Rahman IA, Shawky S, Bahaa T, Elkamhawi S, El Sattar AA, et al. HIV prevalence and risk behaviors of male injection drug users in Cairo, Egypt. AIDS 2010; 24(suppl 2):S33–S38.

9. Nada KH, Suliman EDA. Violence, abuse, alcohol and drug use, and sexual behaviors in street children of Greater Cairo and Alexandria, Egypt. AIDS 2010; 24(suppl 2):S39–S44.

10. Abdelrahim MS. HIV prevalence and risk behaviors of female sex workers in Khartoum, north Sudan. AIDS 2010; 24(suppl 2):S55–S60.

11. Kriitmaa K, Osman m, Bozecevic I, Riedner G, Abdalla I, Malungu J, et al. HIV prevalence and characteristics of sex work among female sex workers in Hargeisa, Somaliland, Somalia. AIDS 2010; 24(suppl 2):S61–S67.

12. Todd CS, Nasir A, Stanekzai MR, Bautista CT, Botros BA, Scott PT, et al. HIV, hepatitis B, and hepatitis C prevalence and associated risk behaviors among female sex workers in three Afghan cities. AIDS 2010; 24(suppl 2):S69–S75.

13. Abu-Raddad L, Akala FA, Semini I, Riedner G, Wilson D, Tawil O, et al. Characterizing the HIV/AIDS epidemic in the Middle East and North Africa: evidence on levels, distribution and trends. Time for Strategic Action. Middle East and North Africa HIV/AIDS Epidemiology Synthesis Project. World Bank/UNAIDS/WHO Publication; 2010.

© 2010 Lippincott Williams & Wilkins, Inc.